Education
About Us
Working with TipRanks
Follow Us
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD)
ASX:RMD
Earnings Data
Report Date
Jan 22, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.42Last Year’s EPS
0.38Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
ResMed's earnings call reflects a strong performance with significant revenue growth, margin expansion, and successful product innovation. The company is effectively leveraging AI and digital health to enhance patient engagement and therapy adherence while maintaining robust shareholder returns. However, challenges persist in the RCS segment, and the impact of global tax legislation has increased operational costs.Company Guidance
Strong Revenue Growth
ResMed reported a 9% revenue growth, or 8% on a constant currency basis, driven by high single-digit growth in devices and double-digit growth in masks and other categories in the U.S., Canada, and Latin America.
Margin Expansion
The global supply chain team delivered a 280 basis points year-over-year gross margin expansion, due to component cost improvements and manufacturing and logistics efficiencies.
Innovation in Product Launches
Launched two new full-face fabric masks, AirTouch F30i comfort and F30i clear, expanding the AirTouch portfolio and enhancing patient comfort and mobility.
Successful Integration and Strategy in RCS Business
ResMed's RCS business delivered mid-single-digit growth, focusing on investing in high-growth, higher-margin SaaS platforms while reducing exposure to lower margin services.
Efforts in AI and Digital Health
Launch of AI-enabled features like Dawn and Comfort Match in the myAir platform to enhance therapy adherence and patient engagement.
Robust Cash Flow and Shareholder Returns
The company generated $457 million in cash flow from operations and returned over $238 million to shareholders through dividends and share repurchases.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) Earnings, Revenues Date & History
AU:RMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AU:RMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 30, 2025 | AU$38.89 | AU$39.53 | +1.65% |
Jul 31, 2025 | AU$42.36 | AU$42.79 | +1.02% |
Apr 23, 2025 | AU$33.11 | AU$35.92 | +8.49% |
Jan 30, 2025 | AU$40.24 | AU$39.92 | -0.80% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) report earnings?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) is schdueled to report earning on Jan 22, 2026, After Close (Confirmed).
What is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) earnings time?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) earnings time is at Jan 22, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock?
The P/E ratio of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh is N/A.
What is AU:RMD EPS forecast?
AU:RMD EPS forecast for the fiscal quarter 2026 (Q2) is 0.42.